美股新聞 標題聯播 · 近 24 小時 337 則 · 29 個來源 · 最新 9/20 04:53
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · MS近 30 天 160 則 · 第 3 / 3 頁
- Halozyme Investor Conferences Put ENHANZE and Expanded Drug Delivery Portfolio in Focus
- Cognex to Present at the Morgan Stanley 14th Annual Laguna Conference
- CG Oncology to Present at Upcoming Investor Conferences in September
- Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
- STERIS (STE) Could Be 12% Below Fair Value As Conference Focus Returns
- STERIS to Present at the Morgan Stanley Healthcare Conference
- Fortive To Present at Morgan Stanley 14th Annual Laguna Conference
- Carrier to Present at Morgan Stanley's 14th Annual Laguna Conference
- Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
- Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
- Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15
- Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference
- Schrödinger to Present at Morgan Stanley Global Healthcare Conference
- DocGo Announces Upcoming Participation at Morgan Stanley 24th Annual Global Healthcare Conference
- PHINIA to Participate in Morgan Stanley’s 14th Annual Laguna Conference
- NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
- Otis CEO to Speak at Morgan Stanley Conference
- Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference
- BioCryst to Present at Upcoming Investor Conference
- Rockwell Automation to Present at Morgan Stanley 14th Annual Laguna Conference
- BeOne Medicines to Present at the Morgan Stanley Annual Global Healthcare Conference
- Sarepta Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
- SI-BONE To Present at Morgan Stanley 24th Global Healthcare Conference on September 14, 2026
- TransMedics to Present at Upcoming September Investor Conferences
- Vir Biotechnology to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
- GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference
- IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
- OnKure Therapeutics to Participate in the Morgan Stanley Global Healthcare Conference
- Kalaris to Present at Morgan Stanley 24th Annual Global Healthcare Conference
- Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference
- LeMaitre to Participate at Upcoming Investor Conferences in September
- Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference
- Want Double-Digit Gains From Insurance Stocks? Morgan Stanley Suggests 2 Names to Consider
- Contineum Therapeutics to Present at the 2026 Morgan Stanley Global Healthcare Conference
- Are Finance Stocks Lagging Morgan Stanley (MS) This Year?
- Werner® to Participate in Morgan Stanley’s 14th Annual Laguna Conference
- Morgan Stanley expects powered-shell deal wave by October
- Quest Diagnostics to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference
- SharpLink’s Ethereum Treasury Draws 60% Institutional Ownership
- Could Canada fully supply the U.S. with aluminium?
- Alignment Healthcare to Present in Baird 2026 Global Healthcare Conference and Attend Morgan Stanley 24th Annual Global Healthcare Conference
- Insilico Medicine Included in MSCI Global Small Cap Indexes, Gaining Capital Market Endorsement in Core Strengths
- MicroStrategy sends harsh response to fresh MSCI delisting threat
- Morgan Stanley Turns More Bullish on IT Hardware as ‘Chipflation’ Drives Faster Spending
- Applied Aerospace & Defense Has Positive Q2 Fundamentals, Morgan Stanley Says
- Morgan Stanley Direct Lending Fund Q2 Earnings Call Highlights
- Morgan Stanley Direct Lending Fund (MSDL) (Q2 2026) Earnings Call Highlights: NII Covers ...
- Morgan Stanley Direct Lending Fund Q2 2026 Earnings Call Summary
- Morgan Stanley Direct Lending Fund (MSDL) Surpasses Q2 Earnings and Revenue Estimates
- Morgan Stanley Direct Lending Fund Announces June 30, 2026 Financial Results and Declares Third Quarter 2026 Regular Dividend of $0.45 per Share
- Compass, Revolve Group Seen With Upside Among Cloud-Based Platform Firms, Morgan Stanley Says
- Immix Biopharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
- Morgan Stanley Picks 2 ‘Strong Buy’ Quality Stocks Built for a Volatile Market
- Analysts Estimate Morgan Stanley Direct Lending Fund (MSDL) to Report a Decline in Earnings: What to Look Out for
- Sinda's Mexico Project Seen as Emerging Major Silver Asset, Morgan Stanley Says
- Morgan Stanley stays bullish on aerospace, defense ahead of Q2 earnings
- Morgan Stanley Direct Lending Fund Announces Second Quarter 2026 Earnings Release and Conference Call
- Morgan Stanley Direct Lending Fund Prices Public Offering of $350.0 Million 6.100% Notes Due 2031
- Morgan Stanley reveals surprising asset exposure
- Morgan Stanley Direct Lending Fund Q1 Earnings Call Highlights
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。